• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    12 Health Care Stocks Moving In Friday's Pre-Market Session

    1/12/24 8:05:59 AM ET
    $ADTX
    $AHG
    $ALRN
    $DRIO
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Real Estate
    Real Estate
    Get the next $ADTX alert in real time by email

    Gainers

    • Jaguar Health (NASDAQ:JAGX) shares moved upwards by 37.0% to $0.15 during Friday's pre-market session. The company's market cap stands at $7.5 million.
    • Jin Medical International (NASDAQ:ZJYL) shares rose 19.23% to $93.0. The market value of their outstanding shares is at $720.7 million.
    • Aileron Therapeutics (NASDAQ:ALRN) stock increased by 18.13% to $4.3. The market value of their outstanding shares is at $21.0 million.
    • Aditxt (NASDAQ:ADTX) shares rose 15.18% to $6.22. The company's market cap stands at $3.0 million.
    • Akso Health Group (NASDAQ:AHG) stock moved upwards by 14.59% to $1.02. The company's market cap stands at $23.3 million.
    • DarioHealth (NASDAQ:DRIO) shares moved upwards by 12.56% to $2.33. The company's market cap stands at $63.4 million.

    Losers

    • Estrella Immunopharma (NASDAQ:ESLA) shares declined by 14.9% to $0.86 during Friday's pre-market session. The market value of their outstanding shares is at $30.2 million.
    • MAIA Biotechnology (AMEX:MAIA) shares declined by 12.77% to $1.23. The company's market cap stands at $20.8 million.
    • Elevance Health (NYSE:ELV) shares decreased by 6.58% to $450.61. The market value of their outstanding shares is at $105.8 billion.
    • Stereotaxis (AMEX:STXS) shares declined by 5.86% to $1.93. The company's market cap stands at $156.1 million.
    • Humana (NYSE:HUM) stock decreased by 5.81% to $428.56. The company's market cap stands at $52.7 billion.
    • Grifols (NASDAQ:GRFS) stock declined by 5.66% to $7.51. The company's market cap stands at $5.0 billion. See Also: www.benzinga.com/money/best-healthcare-stocks/

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $ADTX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADTX
    $AHG
    $ALRN
    $DRIO

    CompanyDatePrice TargetRatingAnalyst
    Humana Inc.
    $HUM
    2/12/2026$189.00Outperform → Sector Perform
    RBC Capital Mkts
    Elevance Health Inc.
    $ELV
    2/3/2026$358.00Outperform → Sector Perform
    RBC Capital Mkts
    Humana Inc.
    $HUM
    2/2/2026$174.00Equal-Weight → Underweight
    Morgan Stanley
    Elevance Health Inc.
    $ELV
    1/8/2026$425.00Peer Perform → Outperform
    Wolfe Research
    Humana Inc.
    $HUM
    1/7/2026$290.00Overweight → Equal Weight
    Wells Fargo
    Elevance Health Inc.
    $ELV
    12/19/2025$320.00Buy → Hold
    Deutsche Bank
    Stereotaxis Inc.
    $STXS
    12/16/2025$4.00Mkt Outperform
    Citizens JMP
    Humana Inc.
    $HUM
    12/5/2025$313.00Hold → Buy
    Jefferies
    More analyst ratings

    $ADTX
    $AHG
    $ALRN
    $DRIO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Humana downgraded by RBC Capital Mkts with a new price target

    RBC Capital Mkts downgraded Humana from Outperform to Sector Perform and set a new price target of $189.00

    2/12/26 8:16:45 AM ET
    $HUM
    Medical Specialities
    Health Care

    Elevance Health downgraded by RBC Capital Mkts with a new price target

    RBC Capital Mkts downgraded Elevance Health from Outperform to Sector Perform and set a new price target of $358.00

    2/3/26 6:49:01 AM ET
    $ELV
    Medical Specialities
    Health Care

    Humana downgraded by Morgan Stanley with a new price target

    Morgan Stanley downgraded Humana from Equal-Weight to Underweight and set a new price target of $174.00

    2/2/26 6:49:06 AM ET
    $HUM
    Medical Specialities
    Health Care

    $ADTX
    $AHG
    $ALRN
    $DRIO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Humana Board Declares Payment of Quarterly Dividend to Stockholders

    Humana Inc. (NYSE:HUM) announced today that its Board of Directors has declared a cash dividend to stockholders of $0.885 per share payable on April 24, 2026 to stockholders of record as of the close of business on March 27, 2026. About Humana Humana (NYSE:HUM) is a leading U.S. healthcare company. Through our Humana insurance services and our CenterWell healthcare services, we make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare and Medicaid, families, individuals, military service personnel, and communities at large.

    2/19/26 6:30:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    Humana Invests $1.7 Million to Drive Better Health Outcomes Across Illinois

    Grants will support key state priorities crucial to improving population health Leading health and wellbeing company Humana Inc. (NYSE:HUM) has committed more than $1.7 million in strategic investments to support housing stability and workforce development, reduce disparities, and expand access to maternal and behavioral healthcare services across Illinois. In partnering with leading community organizations who have a keen understanding of their neighbors' needs, Humana is further addressing its commitment to address health-related social needs and advance priorities outlined by the Illinois Department of Healthcare and Family Services (HFS). This press release features multimedia. View

    2/18/26 8:45:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    CenterWell Completes Acquisition of MaxHealth from Arsenal Capital Partners

    MaxHealth is a Florida-based primary care organization with a network of 82 owned and affiliated clinics, providing care to more than 80,000 patients in value-based care programs.CenterWell Senior Primary Care is the nation's largest senior-focused, value-based primary care provider.The acquisition will expand the reach of CenterWell Senior Primary Care to new key markets and allow it to serve more patients with CenterWell's unique approach to personalized and integrated care.LOUISVILLE, Ky. and TAMPA, Fla. and NEW YORK, Feb. 13, 2026 /PRNewswire/ -- CenterWell, the healthcare services division of Humana Inc., today announced the successful completion of its acquisition of MaxHealth from Ars

    2/13/26 4:15:00 PM ET
    $HUM
    Medical Specialities
    Health Care

    $ADTX
    $AHG
    $ALRN
    $DRIO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Information Officer Mehta Japan converted options into 1,682 units of Humana Common and covered exercise/tax liability with 430 units of Humana Common, increasing direct ownership by 19% to 7,728 units (SEC Form 4)

    4 - HUMANA INC (0000049071) (Issuer)

    2/18/26 12:42:37 PM ET
    $HUM
    Medical Specialities
    Health Care

    Chief Financial Officer Mellet Celeste covered exercise/tax liability with 4,204 units of Humana Common and converted options into 7,763 units of Humana Common, increasing direct ownership by 17% to 24,250 units (SEC Form 4)

    4 - HUMANA INC (0000049071) (Issuer)

    2/18/26 12:40:18 PM ET
    $HUM
    Medical Specialities
    Health Care

    President, Medicare Advantage Martin Aaron was granted 17,031 units of Humana Common (SEC Form 4)

    4 - HUMANA INC (0000049071) (Issuer)

    2/17/26 10:38:23 AM ET
    $HUM
    Medical Specialities
    Health Care

    $ADTX
    $AHG
    $ALRN
    $DRIO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Smith Stan bought $9,959 worth of shares (2,700 units at $3.69) and received a gift of 20,000 shares (SEC Form 4)

    4 - MAIA Biotechnology, Inc. (0001878313) (Issuer)

    1/12/26 8:44:30 AM ET
    $MAIA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Smith Stan bought $69,999 worth of shares (57,189 units at $1.22) (SEC Form 4)

    4 - MAIA Biotechnology, Inc. (0001878313) (Issuer)

    12/23/25 8:18:50 AM ET
    $MAIA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Chaouki Steven M bought $49,999 worth of shares (40,849 units at $1.22), increasing direct ownership by 37% to 151,873 units (SEC Form 4)

    4 - MAIA Biotechnology, Inc. (0001878313) (Issuer)

    12/23/25 8:16:48 AM ET
    $MAIA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADTX
    $AHG
    $ALRN
    $DRIO
    SEC Filings

    View All

    SEC Form 10-K filed by Humana Inc.

    10-K - HUMANA INC (0000049071) (Filer)

    2/19/26 2:26:32 PM ET
    $HUM
    Medical Specialities
    Health Care

    Jaguar Health Inc. filed SEC Form 8-K: Other Events, Material Modification to Rights of Security Holders, Regulation FD Disclosure

    8-K - Jaguar Health, Inc. (0001585608) (Filer)

    2/18/26 9:01:37 AM ET
    $JAGX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 424B3 filed by Estrella Immunopharma Inc.

    424B3 - Estrella Immunopharma, Inc. (0001844417) (Filer)

    2/13/26 5:28:29 PM ET
    $ESLA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ADTX
    $AHG
    $ALRN
    $DRIO
    Leadership Updates

    Live Leadership Updates

    View All

    Humana Announces Insurance Leadership Transition

    George Renaudin to Retire as Insurance Segment President by Q3 2026 Aaron Martin to Join as President of Medicare Advantage and Insurance Segment President Successor John Barger to Succeed Martin as President of Medicare Advantage Humana Inc. (NYSE:HUM) today announced that George Renaudin, Insurance Segment President and member of Humana's Enterprise Leadership Team, will retire by Q3 2026 following a successful 29-year career at the company. During this period, Renaudin played a pivotal role in establishing and growing Humana's Medicare Advantage and Medicaid programs, helping to build them into high-performing businesses and assembling a strong insurance leadership team. "George has co

    12/16/25 8:05:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    Elevance Health Board Welcomes Amy Schulman as New Director, Reflecting Ongoing Commitment to Governance Excellence

    The board of directors of Elevance Health (NYSE:ELV) today announced the appointment of Amy Schulman, a recognized healthcare executive, investor, and governance leader, as an independent director, effective January 12, 2026. Schulman will serve on the Audit and Finance Committees, contributing deep expertise in healthcare innovation, regulatory strategy, and value creation across complex, global enterprises. This appointment reflects Elevance Health's ongoing board refreshment strategy to ensure diverse, independent, and future-focused leadership that aligns with the company's long-term strategy and stakeholders' priorities. "Amy's record of driving innovation, disciplined investment, an

    12/10/25 4:30:00 PM ET
    $ELV
    Medical Specialities
    Health Care

    Stereotaxis Technology to be Featured at Heart Rhythm Society's HRX 2025

    ST. LOUIS, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE:STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced its technology will be featured during the upcoming HRX digital health conference taking place September 4-6, 2025, in Atlanta, Georgia. HRX, an initiative pioneered by the Heart Rhythm Society, is focused on exploring digital technologies that advance the frontiers of cardiovascular medicine. Stereotaxis CEO, David Fischel, will participate in a roundtable discussion on September 5th at 3:45 PM EDT. Later that day, at 4:45 PM EDT, a distinguished panel of electrophysiologists, including Dr. Daniel Cooper,

    8/28/25 7:47:00 AM ET
    $STXS
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $ADTX
    $AHG
    $ALRN
    $DRIO
    Financials

    Live finance-specific insights

    View All

    Humana Board Declares Payment of Quarterly Dividend to Stockholders

    Humana Inc. (NYSE:HUM) announced today that its Board of Directors has declared a cash dividend to stockholders of $0.885 per share payable on April 24, 2026 to stockholders of record as of the close of business on March 27, 2026. About Humana Humana (NYSE:HUM) is a leading U.S. healthcare company. Through our Humana insurance services and our CenterWell healthcare services, we make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare and Medicaid, families, individuals, military service personnel, and communities at large.

    2/19/26 6:30:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    Stereotaxis to Report Fourth Quarter and Full Year 2025 Financial Results on March 9, 2026

    ST. LOUIS, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE:STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will release financial results for its 2025 fourth quarter and full year on Monday, March 9, 2026 at the close of the U.S. financial markets. The Company will host a conference call and webcast at 4:30 p.m. ET that day to discuss the Company's results and corporate developments. What:Stereotaxis fourth quarter and full year 2025 financial results conference callWhen:Monday, March 9, 2026, at 4:30 p.m. ET (1:30 p.m. PT)Dial In Number:To access the live call, dial 800-715-9871 (US and Canada) or 646-30

    2/12/26 9:00:00 AM ET
    $STXS
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Humana Reports Fourth Quarter 2025 Financial Results; Provides Full Year 2026 Financial Guidance

    Reports 4Q25 net loss per share of $6.61 on a GAAP basis, Adjusted net loss per share of $3.96; reports full year (FY) 2025 earnings per share (EPS) of $9.84 on a GAAP basis, $17.14 on an Adjusted basis; quarterly and FY Adjusted results in line with management's expectations 4Q25 Insurance segment GAAP benefit ratio of 93.1 percent; FY 2025 Insurance segment GAAP benefit ratio of 90.4 percent, slightly better than guidance of 'the top end of the range of 90.1 percent to 90.5 percent' Introduces FY 2026 GAAP EPS guidance of 'at least $8.89'; 'at least $9.00' on an Adjusted basis; the anticipated year-over-year decline results from the Star Ratings headwind for Bonus Year 2026, net of

    2/11/26 6:00:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    $ADTX
    $AHG
    $ALRN
    $DRIO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by DarioHealth Corp.

    SC 13G - DarioHealth Corp. (0001533998) (Subject)

    12/13/24 4:05:12 PM ET
    $DRIO
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by Elevance Health Inc.

    SC 13G/A - Elevance Health, Inc. (0001156039) (Subject)

    11/14/24 1:22:35 PM ET
    $ELV
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13G/A filed by Grifols S.A.

    SC 13G/A - Grifols SA (0001438569) (Subject)

    11/14/24 11:46:03 AM ET
    $GRFS
    Biotechnology: Pharmaceutical Preparations
    Health Care